AQA
ABBV icon

Alpha Quant Advisors’s AbbVie ABBV Stock Holding History

Alpha Quant Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.07M Sell
13,315
-332
-2% -$27.2K 1.08% 40
2018
Q4 		$1.26M Buy
+13,647
New +$1.2M 1.31% 16

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha Quant Advisors's ABBV Position: Q1 2019 in Review

Alpha Quant Advisors reduced its AbbVie (ABBV) stake by 2.4% in Q1 2019, selling an estimated $27.2K and leaving 13,315 shares worth $1.07M. The position accounts for 1.08% of the portfolio, ranked #40.

Alpha Quant Advisors first reported a position in ABBV in Q4 2018 and has held it in 2 quarters since. The position peaked at $1.26M in Q4 2018. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • Alpha Quant Advisors held 13,315 shares of AbbVie worth $1.07M as of Q1 2019.
  • Alpha Quant Advisors sold 332 AbbVie shares in Q1 2019, an estimated $27.2K.
  • AbbVie made up 1.08% of Alpha Quant Advisors's portfolio in Q1 2019, its #40 holding.
  • Alpha Quant Advisors first reported a position in AbbVie in Q4 2018 and has held it in 2 quarters since.
  • Alpha Quant Advisors's AbbVie position peaked at $1.26M in Q4 2018.
  • 2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.